ArticleBMC cancer2025
Allostatic load and kidney cancer incidence and mortality: a genetic susceptibility and proteomic mediation analysis.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Allostatic load in female cancer patients: a systematic review.Frontiers in endocrinology · 2026Pooled it
- Association Between Allostatic Load, Genetic Susceptibility, and Liver Cancer Incidence: A Large-Scale Prospective Cohort Study.International journal of cancer · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundAllostatic load (AL), reflecting chronic physiological stress across neuroendocrine, immune, and metabolic systems, may contribute to the onset and prognosis of multiple cancers via inflammation and stress-related injury. However, the associations between AL and kidney cancer (KC) remain unclear. And large-scale evidence linking AL to KC risk, prognosis, and molecular mechanisms is lacking.
methodsIn this Prospective UK Biobank cohort study, 334,754 Participants were analyzed for KC incidence, 357 KC Patients for mortality, and 36,120 participants for proteomic mediation. Proteomic mediation was performed using Med4way analysis; protein trajectories were analyzed using locally weighted regression smoothing (LOESS) regression. The expression profiles of key mediator genes were validated by single-cell RNA sequencing. Enrichment analyses were conducted to characterize mediator proteins by biological pathways, tissue specificity, and cell-type distribution. An AL-mediated proteins-based prediction model was developed via LASSO-Cox regression.
resultsDuring mean follow-up of 13.2 years, participants in the highest AL quintile had increased KC incidence (HR 1.70, 95% CI 1.38-2.10). Among KC patients, high AL was associated with increased mortality (HR 3.10, 95% CI 1.51-6.36). Proteins mediating AL-KC associations included HAVCR1, GDF15, TNFRSF11A, FSTL3, and CD83; HAVCR1 showed strongest mediation (72.69%) and distinct pre-diagnostic trajectory. Functional enrichment revealed these proteins were jointly involved in immune regulation, stress response, and epithelial signaling pathways. The predictive model incorporating NOS3, SULT2A1, HAVCR1, FSTL3, and sex achieved robust performance (10-year AUC 0.80) for KC Prediction.
conclusionsAL is associated with increased KC incidence and mortality, mediated through inflammatory and metabolic proteins. These findings underscore chronic physiological stress as a significant factor in KC pathogenesis, providing potential biomarkers for early risk assessment and targeted prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.